Tasca Therapeutics Corp research brief

CIK 2046762 Copy CIK

Generated Nov. 15, 2026, 8:39 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: CAMBRIDGE Massachusetts. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.

• Dec. 1, 2025 · D/A · 0002046762-25-000005 · Source evidence

  Reported offering amount: 70199981 USD. Reported amount sold: 48099985 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “Tasca Therapeutics Corp research brief,” CIK 2046762, retrieved Nov. 15, 2026, 8:39 p.m.. Cite the specific accessions used. No amounts have been summed.